Procyshyn RM, Su J, Elbe D, Liu AY, Panenka WJ, Davidson J, et al. Prevalence and patterns of antipsychotic use in youth at the time of admission and discharge from an inpatient psychiatric facility. J Clin Psychopharmacol. 2014;34(1):17-22. DOI: 10.1097/JCP.0b013e3182a607dd. PubMed PMID: 24346744.
Katona L, Czobor Pál, Bitter I. Real-world effectiveness of antipsychotic monotherapy vs. polypharmacy in schizophrenia: to switch or to combine? A nationwide study in Hungary. Schizophr Res. 2014;152(1):246-54. DOI: 10.1016/j.schres.2013.10.034. PubMed PMID: 24275583.
Tseng A, Szadkowski L, Walmsley S, Salit I, Raboud J. Association of age with polypharmacy and risk of drug interactions with antiretroviral medications in HIV-positive patients. Ann Pharmacother. 2013;47(11):1429-39. DOI: 10.1177/1060028013504075. PubMed PMID: 24285760.
Watanabe JH, Bounthavong M, Chen T, Ney JP. Association of polypharmacy and statin new-user adherence in a Veterans Health Administration population: a retrospective cohort study. Ann Pharmacother. 2013;47(10):1253-9. DOI: 10.1177/1060028013502000. PubMed PMID: 24259688.
van Wattum PJ, Fabius C, Roos C, Smith C, Johnson T. Polypharmacy reduction in youth in a residential treatment center leads to positive treatment outcomes and significant cost savings. J Child Adolesc Psychopharmacol. 2013;23(9):620-7. DOI: 10.1089/cap.2013.0014. PubMed PMID: 24251644.
Kelleher T, Cross A, Dunkle L. Relation of peripheral neuropathy to HIV treatment in four randomized clinical trials including didanosine. Clin Ther. 1999;21(7):1182-92. DOI: 10.1016/S0149-2918(00)80021-1. PubMed PMID: 10463516.
Gareri P, De Fazio P, Manfredi VGL, De Sarro G. Use and safety of antipsychotics in behavioral disorders in elderly people with dementia. J Clin Psychopharmacol. 2014;34(1):109-23. DOI: 10.1097/JCP.0b013e3182a6096e. PubMed PMID: 24158020.